BioSig Technologies Announces Participation in Lafayette College’s InternShift Summer Program
Mar 30, 2017 12:01 pm UTC| Business
Minneapolis, MN, March 30, 2017 -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4...
KaloBios to Participate in Inaugural U.S. Chagas Conference
Mar 30, 2017 12:01 pm UTC| Business
BRISBANE, Calif., March 30, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced that Cameron Durrant,...
Mar 30, 2017 12:01 pm UTC| Business
NEW YORK, March 30, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Pacific Mercantile Bank Provides $3 Million in Financing to Platinum Roofing
Mar 30, 2017 12:01 pm UTC| Business
COSTA MESA, Calif., March 30, 2017 -- Pacific Mercantile Bank (“the Bank”), the wholly owned subsidiary of Pacific Mercantile Bancorp (NASDAQ:PMBC), today announced that it has extended a $3 million credit facility to...
CRISPR Therapeutics to Present at the 16th Annual Needham Healthcare Conference
Mar 30, 2017 12:01 pm UTC| Business
BASEL, Switzerland and CAMBRIDGE, Mass., March 30, 2017 -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today...
Semtech Hosts 5th Annual Charity Golf Tournament Supporting Ventura County Youth
Mar 30, 2017 12:00 pm UTC| Business
CAMARILLO, Calif., March 30, 2017 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of analog and mixed-signal semiconductors, will host its fifth annual mid-season charity golf tournament on June 16 at the River...
CymaBay Therapeutics to Present at Two Investor Conferences in April
Mar 30, 2017 12:00 pm UTC| Business
NEWARK, Calif., March 30, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced...